Patrick Alias - 16 Feb 2023 Form 4 Insider Report for COGNEX CORP (CGNX)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
21 Feb 2023, 15:06:18 UTC
Prior SEC filing
24 Feb 2022
Next SEC filing
23 Feb 2023
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
Patrick Alias

Key filing fact

Patrick Alias filed Form 4 for COGNEX CORP (CGNX) on 21 Feb 2023.

Key facts

  • This page summarizes Patrick Alias's Form 4 filing for COGNEX CORP (CGNX).
  • 4 reported transactions and 8 derivative rows are listed below.
  • Accepted by SEC: 21 Feb 2023, 15:06.

Change

  • Previous filing in this sequence was filed on 24 Feb 2022.
  • Current net transaction value: -$46,719.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CGNX transaction

Common Stock

Options Exercise

Transaction value
$0
Shares
+912
Change %
Price
$0.000000
Shares after
912
Date
16 Feb 2023
Ownership
Direct
CGNX transaction

Common Stock

Tax liability

Transaction value
$14,989
Shares
-271
Change %
-30%
Price
$55.31
Shares after
641
Date
16 Feb 2023
Ownership
Direct
Footnotes
F1
CGNX transaction

Common Stock

Sale

Transaction value
$31,730
Shares
-641
Change %
-100%
Price
$49.50
Shares after
0
Date
17 Feb 2023
Ownership
Direct
Footnotes
F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CGNX transaction Derivative

Restricted Stock Unit

Options Exercise

Transaction value
$0
Shares
-912
Change %
-38%
Price
$0.000000
Shares after
1,519
Date
16 Feb 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
912
Exercise price
$0.000000
Footnotes
F3, F4
CGNX holding Derivative

Non-Qualified Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
17,500
Date
16 Feb 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
17,500
Exercise price
$16.72
CGNX holding Derivative

Non-Qualified Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
35,000
Date
16 Feb 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
35,000
Exercise price
$38.39
CGNX holding Derivative

Non-Qualified Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
30,750
Date
16 Feb 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
30,750
Exercise price
$50.94
CGNX holding Derivative

Non-Qualified Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
35,000
Date
16 Feb 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
35,000
Exercise price
$51.49
CGNX holding Derivative

Non-Qualified Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
17,500
Date
16 Feb 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
17,500
Exercise price
$56.44
CGNX holding Derivative

Non-Qualified Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
2,231
Date
16 Feb 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
2,231
Exercise price
$90.50
CGNX holding Derivative

Restricted Stock Unit

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
4,269
Date
16 Feb 2023
Ownership
Direct
Underlying class
Common Stock
Underlying amount
4,269
Exercise price
$0.000000
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

This disposition represents shares withheld to satisfy tax withholding obligations on the restricted stock units that vested on February 16, 2023 and are reported herein.

Footnote F2

These shares were disposed of in an open market sale pursuant to a trading plan adopted by the reporting person in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.

Footnote F3

Each restricted stock unit represents a contingent right to receive one share of Cognex Corporation common stock.

Footnote F4

The restricted stock units vest approximately 20%, 30%, and 50% on the first, second, and third anniversaries of the grant date (February 16, 2021), respectively.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .